Summary
Sxity-five tumors of invasive ductal carcinoma of the breast were examined for p53 alteration by the reverse transcription-polymerase chain reaction-single strand conformation polymorphism (RT-PCR-SSCP) method and sequencing analysis. In total, 16 samples (24.6%) showed p53 gene alteration. Sixteen of these alterations were evaluated by sequencing analysis, and 15 showed missense point mutations while one showed a 9-base pair deletion. In the 15 point mutations, G:C to A:T transitions constituted the majority (53%), and five tumors (33%) had a transition at the CpG site, which are mutational patterns not commonly found in breast tumors from Europe and America. On the other hand, there were no G:C to T:A transversions in our cases, which were frequently observed transversions in Europe and America. These p53 mutation patterns in breast cancer in Japan are not similar to those in Europe and America reported by Hollsteinet al. and Coleset al.. These findings suggest that there are some differences between mechanisms of breast cancer in Japan and in Europe and America.
This is a preview of subscription content, log in via an institution to check access.
References
Sakamoto G, Sugano H, Hartmann WH: Comparative clinico-pathological study of breast cancer among Japanese and American females. Jpn J Cancer Clin 25: 161–170, 1979
Iwaya K, Tsuda H, Hiraide H, Tamaki K, Tamakawa S, Fukutomi T, Mukai K, Hirohashi S: Nuclear p53 immunoreaction associated with poor prognosis of breast cancer. Jpn J Cancer Res 82: 835–840, 1991
Hollstein M, Sidransky D, Vogelstein B, Harris CC: p53 mutations in human cancers. Science 253: 49–53, 1991
Davidoff AM, Humphrey PA, Iglehart JD, Marks JR: Genetic basis for p53 overexpression in human breast cancer. Proc Natl Acad Sci USA 88: 5006–5010, 1991
Coles C, Condie A, Chetty U, Steel CM, Evans HJ, Prosser J: p53 mutations in breast cancer. Cancer Res 52: 5291–5298, 1992
Tsuda H, Iwaya K, Fukutomi T, Hirohashi S: p53 mutations and c-erbB-2 amplification in intraductal and invasive breast carcinomas of high histologic grade. Jpn J Cancer Res 84: 394–401, 1993
Hartmann WH, Ozzello L, Sobin LH, Stalsberg H: ‘Histological typing of breast tumors.’ 2nd Ed, Geneva, World Health Organization, 1987
Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162: 156–159, 1987
Kondo K, Umemoto A, Akimoto S, Uyama T, Hayashi K, Ohnishi Y, Monden Y: Mutations in p53 tumour suppressor gene in primary lung cancer in Japan. Biochem Biophys Res Commun 183: 1139–1146, 1992
Mashiyama S, Sekiya T, Hayashi K: Screening of multiple DNA samples for detection of sequence changes. J Meth Mol Bio 12: 304–306, 1990
Trichopoulos D, Yen S, Brown J, Cole P, McMahon B: The effect of westernization on urine estrogens, frequency of ovulation, and breast cancer risk. Cancer 53: 187–192, 1984
Varley JM, Brammar WJ, Lane DP, Swallow JE, Dolan C, Walker RA: Loss of chromosome 17p13 sequences and mutation of p53 in human breast cancer. Oncogene 6: 413–421, 1991
Baker SJ, Markowitz S, Fearon ER, Willson JKV, Vogelstein B: Suppression of human colorectal carcinoma cell growth by wild-type p53. Science 249: 912–915, 1990
Runnebaum IB, Nagarajan M, Bowman M, Sato D, Sukumar S: Mutations in p53 as potential molecular markers for human breast cancer. Proc Natl Acad Sci USA 88: 10657–10661, 1991
Osborne RJ, Merlo GR, Mitsudomi T, Venesio T, Liscia DS, Cappa APM, Chiba I, Takahashi T, Nau MM, Callahan R, Minna JD: Mutation in the p53 gene in primary human breast cancer. Cancer Res 51: 6194–6198, 1991
Sved J, Bird A: The expected equilibrium of the CpG dinucleotide in vertebrate genomes under a mutation model. Proc Natl Acad Sci USA 87: 4692–4696, 1990
Mazur M, Glickman BW: Sequence specificity of mutations induced by benzo pyrene-7,8-diol-9,10-epoxide at endogeneousapart gene in CHO cells. Som Cell Mol Gen 14: 393–400, 1988
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Sasa, M., Kondo, K., Komaki, K. et al. Frequency of spontaneous p53 mutations (CpG site) in breast cancer in Japan. Breast Cancer Res Tr 27, 247–252 (1993). https://doi.org/10.1007/BF00665694
Issue Date:
DOI: https://doi.org/10.1007/BF00665694